Press Releases & News

SAN DIEGO, Nov. 6, 2018  -- Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of cell-delivered oncolytic viruses for the treatment of cancer, today announced that data from its clinical studies in late-stage cancer patients will be presented at the Society for Immunotherapy of Cancer…

SAN DIEGO, October 25, 2018 - Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced that it has been granted a new patent from the United States Patent Office (USPTO). Patent Number: 10,105,436 "Smallpox Vaccine for Cancer Treatment" covers the use…

SAN DIEGO, May 24, 2018 -- Calidi Biotherapeutics, Inc., a clinical‐stage biotherapeutics company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced a focused effort to advance its oncolytic virus drug development. Calidi Biotherapeutics is developing a novel cell-based platform for delivery of oncolytic viruses, which…